Substandard and Falsified Medications: A Barrier to Global Health Equity Exemplified in Ecuador
- PMID: 36517662
- PMCID: PMC9750049
- DOI: 10.1007/s12028-022-01658-1
Substandard and Falsified Medications: A Barrier to Global Health Equity Exemplified in Ecuador
Erratum in
-
Correction: Substandard and Falsifed Medications: A Barrier to Global Health Equity Exemplifed in Ecuador.Neurocrit Care. 2023 Feb;38(1):218. doi: 10.1007/s12028-022-01668-z. Neurocrit Care. 2023. PMID: 36580237 Free PMC article. No abstract available.
Abstract
Medicines have been developed and have become globalized at a pace faster than traditional medical education can keep up. Physicians, pharmacists, nurses, and advanced practice providers learn the names and functions of these medications, but not how they are made and how they get to the bedside. The often economically driven intricacies behind these processes have a dramatic effect on patient care and outcomes. A staggering proportion of medications worldwide are reported to be substandard or falsified. This article explores one country's story of how medication gets to the bedside, describes how this process can go wrong, and outlines what providers can do to work toward the goal of equitable access to quality medications for all.
Keywords: Falsified medications; Global health; Substandard medications.
© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Conflict of interest statement
The authors have no conflict of interest.
References
-
- WHO global surveillance and monitoring system for substandard and falsified medical products. 2017. https://www.who.int/publications/i/item/9789241513425
-
- Rago L. Drug regulation: history, present and future. drug benefits and risks: international textbook of clinical pharmacology, revised 2nd edition. IOS Press and Uppsala Monitoring Centre; 2008:65–77.
-
- Holmes EM. Pharmacopoeia. In: Chisholm H, editor. Encyclopædia Britannica. 11. Cambridge University Press; 1911. pp. 353–355.
-
- Eban K. Bottle of lies: the inside story of the generic drug boom. HarperCollins Publishers; 2019.
-
- Administration FaD. Milestones in U.S. Food and Drug law. https://www.fda.gov/about-fda/fdas-evolving-regulatory-powers/milestones... Accessed 22 February 2020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical